Immunosuppressive treatment of multiple sclerosis. 3. Results of treatment with azathioprine and antilymphocytic globulin
Frick, E.; Angstwurm, H.; Strauss, G.
Münchener Medizinische Wochenschrift 116(48): 2105-2112
1974
ISSN/ISBN: 0341-3098 PMID: 4216823 Document Number: 70656
Document emailed within 1 workday
Related Documents
Cendrowski, W. 1972: Antilymphocytic globulin and its immunosuppressive action in experimental allergic encephalomyelitis and multiple sclerosis Neurologia i Neurochirurgia Polska 6(4): 619-623Lhermitte, F.; Marteau, R.; de Saxcé, H. 1987: Treatment of progressive and severe forms of multiple sclerosis using a combination of antilymphocyte serum, azathioprine and prednisone. Clinical and biological results. Comparison with a control group treated with azathioprine and prednisone only. 4-year follow-up Revue Neurologique (Paris) 143(2): 98-107
Canafax, D.M.; Simmons, R.L.; Sutherland, D.E.; Fryd, D.S.; Strand, M.H.; Ascher, N.L.; Payne, W.D.; Najarian, J.S. 1986: Early and late effects of two immunosuppressive drug protocols on recipients of renal allografts: results of the Minnesota randomized trial comparing cyclosporine versus antilymphocyte globulin-azathioprine Transplantation Proceedings 18(2 Suppl 1): 192-196
Skłodowski, P. 1993: Critical opinions on the treatment of multiple sclerosis with immunosuppressive agents Neurologia i Neurochirurgia Polska 27(6): 877-883
Rubio-Terrés, C.; Domínguez-Gil Hurlé, A. 2005: Cost-utility analysis of relapsing-remitting multiple sclerosis treatment with azathioprine or interferon beta in Spain Revista de Neurologia 40(12): 705-710
Tourtellotte, W.W.; Syndulko, K.; Baumhefner, R.W.; Shapshak, P.; Osborne, M. 1988: A comprehensive protocol for clinical trials in multiple sclerosis which favored azathioprine and corticosteroid as a type of treatment for the chronic progressive phase Neurology 38(7 Suppl 2: 83-86
Iusubov, I.A. 1975: Use of stimulating doses of antilymphocytic gamma globulin in the complex treatment of chronic osteomyelitis of the lower limbs Vrachebnoe Delo 4: 98-100
Cosi, V.; Lombardi, M.; Erbetta, A.; Piccolo, G. 1993: Azathioprine as a single immunosuppressive drug in the treatment of myasthenia gravis Acta Neurologica 15(2): 123-131
Bykova, O.V.; Nankina, I.A.; Platonova, A.N.; Karpacheva, N.G.; Petrova, O.A.; Gorina, T.P.; Batysheva, T.T.; Serkov, S.V.; Kuzenkova, L.M. 2013: Differential diagnosis of multiple sclerosis with pediatric onset: the experience of the Moscow Division for treatment of children and adolescents with multiple sclerosis Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 113(10 Pt 2): 61-68
Bednaăík, T.; Cajthamlová, H. 1976: Suppression of humoral antibody formation in rabbits. Administration of alpha globulin fraction of human plasma and antilymphocytic globulin Casopis Lekaru Ceskych 115(48): 1490-1492
Wender, M.; Tokarz-Kupczyk, E.; Mularek, O. 1989: Late results of the treatment of the chronic progressive form of multiple sclerosis by intensive immunosuppression Neurologia i Neurochirurgia Polska 23(3): 188-192
Wender, M.; Tokarz-Kupczyk, E.; Mularek, O. 1988: Early results of the treatment of chronic progressive forms of multiple sclerosis with cyclophosphamide and ACTH Neurologia i Neurochirurgia Polska 22(5): 399-403
Saida, T. 2004: Multiple sclerosis: treatment and prevention of relapses and progression in multiple sclerosis Rinsho Shinkeigaku 44(11): 796-798
Wong, C.F.; Beshir, S.; Khalil, A.; Pai, P.; Ahmad, R. 2005: Successful treatment of encapsulating peritoneal sclerosis with azathioprine and prednisolone Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 25(3): 285-287
Popova, E.V.; Brylev, L.V.; Davydovskaia, M.V. 2013: Natalizumab in the treatment of patients with relapsing-remitting multiple sclerosis: the preliminary results of the observational program "Sovet" Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 113(2 Pt 2): 79-82
Kostecki, J.; Zaniewski, M.; Ziaja, K.; Urbanek, T.; Kuczmik, W.; Krzystanek, E.; Ziaja, D.; Korzeniowski, T.; Majewski, E.; Hartel, M.; Swiat, M.; Sioma-Markowska, U. 2011: An endovascular treatment of Chronic Cerebro-Spinal Venous Insufficiency in multiple sclerosis patients - 6 month follow-up results Neuro Endocrinology Letters 32(4): 557-562
Peraldi, M.N.; Rondeau, E.; Bellaj, A.; Kanfer, A.; Sraer, J.D. 1988: Association of cytomegalovirus infection and immunosuppressive treatment with cyclosporine A and antilymphocyte globulin in renal transplant recipients Clinical Nephrology 29(1): 52
Gruber, S.A.; Pescovitz, M.; Simmons, R.L.; Najarian, J.S.; Ascher, N.L.; Payne, W.D.; Sutherland, D.E.; Elick, B.; Fryd, D.S. 1987: Thromboembolic complications after renal transplantation: results from the randomized trial of cyclosporine v azathioprine-antilymphocyte globulin Transplantation Proceedings 19(1 Pt 2): 1815-1816
Alonso, K.; Medenica, R. 1995: Immunomodulation in the treatment of multiple sclerosis and amyotrophic lateral sclerosis: a model for autoimmune disorders Journal of the National Medical Association 87(8): 561-568
Kerstens, P.J.; Boerbooms, A.M.; Jeurissen, M.E.; de Graaf, R.; Mulder, J.; van de Putte, L.B. 2000: Radiological and clinical results of longterm treatment of rheumatoid arthritis with methotrexate and azathioprine Journal of Rheumatology 27(5): 1148-1155